We semiquantitatively monitored the incorporation of host membrane proteins on different strains of human immunodeficiency virus type 1 (HIV-1) grown in several human CD4/ lymphoid cell lines and in primary mitogen-stimulated peripheral blood mononuclear cells. The relative amounts of virally acquired cell proteins were estimated by the ability of HIV-1 to be captured by magnetic beads coated with monoclonal antibodies. Here we report that, among host surface proteins studied, HLA-DR molecules were the most abundant virion-bound host molecules. We have also found that, in contrast to previous studies, HLA-DP and -DQ isotypes were also present on virus progeny. More importantly, we determined that the relative levels of virally acquired host HLA-DR proteins, as estimated by capture with immunomagnetic beads, greatly differed depending on the virus strain and the producer cell. These observations extend beyond already published results and suggest that the process of incorporation of cellular molecules on newly released virus particles is a phenomenon that relies on both the virus strain and producer cell line. These in vitro observations are of prime importance considering that virus-acquired host molecules have been recently shown to affect the biology of HIV. ᭧
INTRODUCTION
host range and influence the course of the disease following infection (Lando et al., 1983; Lee et al., 1982) . Infection of susceptible cells with the human immuno-Similar studies were extended to HIV and it was shown deficiency virus (HIV) occurs via interaction between the that this retrovirus could also incorporate several cell external viral envelope glycoprotein gp120 and the CD4 membrane proteins including HLA-DR, b 2 -microglobulin, molecule displayed on the host cell surface (Dalgleish ICAM-1, LFA-1, CD43, CD44, CD63, and the transferrin et al., 1984; Klatzmann et al., 1984) . In addition to this receptor (CD71) (Arthur et al., 1992; Benkirane et al., 1994 ; virally encoded surface protein, whose function has been Capobianchi et al., 1994;  Fais et extensively studied, other molecules have been demonal., 1995; Gelderblom et al., 1987a; Henderson et al., strated to be present on the virus surface. The incorpora-1987; Hoxie et al., 1987; Meerloo et al., 1992 Meerloo et al., , 1993 ; Orention of cellular constituents on virus particles has been tas and Hildreth, 1993; Schols et al., 1992) . For example, reported to occur in retroviruses as they bud from in- Arthur et al. (1992) have reported that the b 2 -microglobufected cells (Azocar and Essex, 1979; Bubbers and Lilly, lin and the a and b chains of MHC-II (DR-isotype) were 1977; de Thé et al., 1964; Gelderblom et al., 1987a; Lando physically associated with the surface of HIV-1, HIV-2, et al., 1983; Lee et al., 1982) . These host constituents, and SIV. An interesting observation of some of these depending on their nature, may directly or indirectly parstudies was that HLA-DR was the only isotype of major ticipate in early events in the virus replicative cycle. It histocompatibiltiy complex class-II molecules (MHC-II) has been shown that acquisition of cellular proteins by found embedded within HIV-1 particles, as HLA-DP and budding viruses is a selective process. In fact, specific HLA-DQ were excluded from the progeny virus (Arthur cellular proteins were detected on virions such as MHCet al., 1992; Henderson et al., 1987; Hoxie et al., 1987) . I molecules on murine leukemia virus (Bubbers and Lilly, Recent studies have provided evidence suggesting 1977), leukocyte alloantigens on feline leukemia virus that virion-embedded host proteins can affect the biology (Lee et al., 1982) , and receptors for interleukin-2 on huof the virus (Gomez and Hildreth, 1995 ; Lee Guo and man T-lymphotropic virus type-I (Lando et al., 1983) . It Saiffudin et al., 1995) . The amount of virally has been postulated that the selective incorporation of acquired cellular molecules could therefore have an imcellular antigens within retroviruses envelope may affect pact on the virus activity. In order to supplement our knowledge with regard to the incorporation of cellular constituents on budding HIV-1 particles, we analyzed dif-nuclear cells. The relative levels of host membrane pro-Ingelheim Pharmaceuticals, Inc., Ridgefield, CO). Antibodies were isolated from hybridoma culture superna-teins incorporated by progeny virus were investigated by monitoring the ability of HIV-1 to be captured by immuno-tants and purified by recombinant protein A/G-Sepharose affinity chromatography. magnetic beads. This technique allowed us to determine the proportion of viruses that expresses on their surface Production of virus particles the threshold number of host molecules required to achieve an efficient immunomagnetic isolation. In this Virus stocks were prepared from acutely infected cells. study, we show that incorporation of cell-derived HLA-DR In brief, human lymphoid cell lines (RAJI-CD4, H9, HUT proteins on HIV-1 is a phenomenon that is quantitatively 78, and Molt 4 clone 8) were infected with various strains modulated by the virus and cell type. This report is the of HIV-1 (LAI, IIIRF, and NL4-3) at a multiplicity of infection first to demonstrate that the process of acquisition of of 0.01 (infectious particle/target cell). At the maximal host proteins by HIV is influenced by both the virus and virus production and before extensive cytopathic effects the producer cell.
were seen, cells were centrifuged at 300 g for 5 min and the virus-containing supernatant was clarified at 2000 g MATERIALS AND METHODS for 30 min and was filtered through a 0.45-mm cellulose acetate membrane to remove cellular debris. Thereafter, Cells the virus-containing supernatant was stored at 080Њ in Cells were maintained in complete culture medium aliquots. HIV-1 LAI was initially harvested from latently inmade of RPMI-1640 supplemented with 10% fetal calf fected ACH-2 cells following treatment with TNF-a. The serum, glutamine (2 mM), penicillin G (100 U/ml), and IIIRF strain of HIV-1 was kindly provided by Dr. R. C. streptomycin (100 mg/ml). RAJI cells, obtained from the Gallo, as cell-free supernatant from infected H9 cells, American Type Culture Collection (Rockville, MD), have through the AIDS Research and Reference Reagent Probeen previously shown to express very high levels of cell gram. Stock of the NL4-3 strain of HIV-1 was prepared surface HLA-DR, -DP, and -DQ proteins (Accolla, 1983) .
by transfecting plasmid DNA into Sup-T1, a CD4/ T-cell RAJI cells were rendered susceptible to HIV-1 infection line highly susceptible and permissive to HIV-1 replicaby transfecting them with the human CD4 cell surface tion (unpublished observations). Transfection of pNL4-3 glycoprotein using an amphotropic retrovirus as dewas achieved by electroporation according to a strandscribed previously (Tremblay et al., 1994) . In brief, CD4 ard protocol (Cann et al., 1988) . The pNL4-3 molecular was introduced into RAJI cells by infection with an amclone of HIV-1 was provided by the AIDS Research and photropic retrovirus vector that contained the human CD4 Reference Reagent Program. Clinical isolates HIV-1 334 , cDNA driven by the cytomegalovirus enhancer/promoter HIV-1 336 , and HIV-1 438 have been described previously region and the neo gene driven by the simian virus 40 (Tremblay et al., 1990) and were produced on phytohepromoter. Stable transfectants of RAJI-CD4 cells were magglutinin-stimulated peripheral blood cells isolated cultured in complete culture medium supplemented with from the same healthy donor. The percentage of pel-1 mg/ml of the selective agent G418 (GIBCO -BRL, letable virus-associated p24 was evaluated by subjecting Gaithesburg, MD). The lymphoblastoid CD4/ T-cell lines each virus stock to ultracentrifugation (Heraeus type HTA H9, HUT 78, and Molt 4 clone 8 were provided by the 13.8 rotor; 12,000 rpm; 90 min at 4Њ). AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH (Rockville, MD).
Detection of cellular molecules incorporated on HIV-1 by immunomagnetic beads Antibodies
Different mouse monoclonal antibodies (OKT3, OKT4, RR1/1.1.1, W6/32, 2.06, B7.21, and BT3.4) were bounded Anti-CD4 (anti-Leu-3A, clone S53) was purchased from Becton-Dickinson Immunocytometry (San Jose, CA).
to BioMag goat anti-mouse IgG particles (Fc specific; PerSeptive Diagnostics, Inc., Cambridge, MA). Briefly, Anti-CD3 (clone OKT3) (Van Wauwe et al., 1980) , anti-MHC-I (clone W6/32) (Brodsky and Parham, 1982) , and magnetic particles were washed four times using a magnetic separation unit with binding buffer made of phos-anti-HLA-DR (clone 2.06) (Charron and McDevitt, 1979) monoclonal antibodies were obtained from the American phate-buffered saline (PBS), pH 7.2, supplemented with 0.1% bovine serum albumin and 0.02% thimerosal. There-Type Culture Collection (Rockville, MD). Anti-HLA-DP (clone B7.21) (Watson et al., 1983) and anti-HLA-DQ after, washed magnetic particles (2.5 1 10 8 ) were incubated overnight at 4Њ using gentle mixing with 40 mg of (clone BT3.4) (Accolla et al., 1982) were kindly provided by Dr R.-P. Sé kaly (Institut de Recherches Cliniques de each antibody. Antibody-coated magnetic particles were washed four times with binding medium and were stored Montré al, Montré al, Qué ., Canada). Anti-HLA-DR, -DP, and -DQ antibodies are directed against monomorphic at 4Њ until used. Similar amounts of each virus stock, standardized by their p24 content (2500 pg), were incu-regions of each molecule. Anti-CD54 (clone RR1/1.1.1) was generously supplied by Dr R. Rothlein (Boehringer bated with antibody-coated magnetic particles (12.5 1 HLA-DR-coated magnetic beads (1.25, 2.5, 6.25, 12.5, 18.75, and 25 1 10 6 ). The amount of viruses captured a Results are the mean of three determinations. All standard deviations were within 10% of the mean. Values shown are expressed in was found to be directly proportional to the amount of picograms of p24.
antibody-coated beads reaching a plateau when using 12.5 1 10 6 antibody-coated magnetic particles. For example, results from one representative experiment demonof paraformaldehyde and analyzed by a cytofluorimeter. strate that 100, 170, 540, 1110, 1100, and 1075 pg of p24
Controls consisted of commercial isotype-matched muwere captured with the use of 1. 25, 2.5, 6.25, 12.5, 18.75, rine monoclonal antibodies (Sigma, St. Louis, MO). and 25 1 10 6 anti-HLA-DR-coated magnetic beads, respectively. Similar standardization experiments were car-Statistical analysis ried out for each monoclonal antibody used in our study.
Statistically significant differences between groups Furthermore, results obtained with magnetic beads were performed with the analysis of variance (ANOVA) coated with OKT3 were used as negative control values module of SAS software (version 6.07, SAS Institute, Cary, because studied cell lines were all negative for cell sur-NC) using the Duncan's multiple range test. P values face CD3 expression (data not shown). Values with anti-õ0.05 were considered statistically significant (P values CD3-coated beads were consistently õ10 pg of p24 and are given in the figure legends). All data are presented have been subtracted from the values shown for other as mean { SEM. antibodies. Capture of HIV-1 NL4-3 (2500 pg of p24) harvested from RAJI-CD4 cells with anti-HLA-DR-coated RESULTS magnetic beads gave intraassay and interassay variations of 8 and 9%, respectively, suggesting that this assay Immunomagnetic recovery of viruses harvested from is reproducible (data not shown). Preliminary experiacutely infected lymphoid cells ments indicated that, in our hands, capture of HIV-1 particles with immunomagnetic beads gave both lower back-Magnetic beads coated with specific monoclonal antibodies were used to detect cell membrane proteins as-ground levels of p24 and better reproducibility than the previously described virus capture assay, which relies on sociated with HIV-1 particles budding from acutely infected cells. First, we have used viruses harvested from the use of ELISA plates coated with specific antibodies (Orentas and Hildreth, 1993) .
a lymphoblastoid B-cell line that is highly susceptible to HIV-1 infection. RAJI-CD4 cells were inoculated with HIV-p24 enzymatic assays 1 NL4-3 and cell-free supernatant was harvested before virus-mediated cytopathic effects were seen. It is of inter-Virus stocks were quantitated by measuring the est to note that extensive cytopathic effects are induced amount of the major viral core p24 protein with the in RAJI-CD4 cells by the majority of laboratory strains of use of a commercial enzymatic test (Organon Teknika, HIV-1, including NL4-3, IIIRF, and LAI (data not shown). Durham, NC).
Results from Table 1 indicate that progeny virus was captured efficiently by magnetic beads coated with Flow cytometry analysis monoclonal antibodies specific for several cell surface molecules. Comparable recovery rate of virus particles Levels of surface molecules were detected by indirect immunofluorescence using a cytofluorimeter. Briefly, 1 was achieved with the use of magnetic beads coated with antibodies against the adhesion molecule ICAM-1 1 10 5 cells were first incubated with an experimentally determined saturating concentration of an appropriate (CD54), MHC-I, and two determinants of MHC-II (HLA-DP and HLA-DQ). Magnetic beads coated with a monoclonal murine monoclonal antibody for 30 min on ice. Samples were washed twice in PBS and incubated for 30 min on antibody directed against a monomorphic epitope of the HLA-DR determinant of MHC-II (clone 2.06) were the ice with a R-PE-conjugated goat anti-mouse IgG. After two washes with PBS, samples were fixed with 1% (w/vol) most efficient to capture viruses harvested from RAJI-CD4 cells. Virus particles recovered with immunomagnetic particles were shown to be infectious when cultured on Sup-T1 cells and the extent of virus yield correlated with the amount of captured virus (data not shown).
A background level of virus recovery was seen with a monoclonal antibody specific for CD4, indicating that this cell surface molecule is not acquired by budding virus progeny. The failure to recover HIV-1 particles with this antibody was not associated with changes in its binding affinity since all cell lines tested in our studies (RAJI-CD4, HUT 78, H9, and Molt 4 clone 8) could be efficiently captured with magnetic beads coated with the same anti-CD4 antibody (data not shown). Furthermore, magnetic beads coated with anti-CD54, -MHC-I, -HLA-DR, -DP, and -DQ antibodies demonstrated also the same capacity to immunoselect studied cell lines expressing the ap- ruses was next investigated with the use of a commercial p24 enzymatic assay. Results shown are the mean of three determinations { SD (*statistically different from other molecules with a P õ 0.0001;
The level of host HLA-DR acquired by HIV-1 is virus **statistically different from other virus strains with a P õ 0.0001).
strain-and cell type-specific
Following the demonstration of the reliability and reone strain to another. Relative differences in the level of producibility of virus capture by immunomagnetic beads, host HLA-DR proteins acquisition are not associated with comparative analysis was next carried out to semiquantia diminished ability of the antibody to react with its ligand tatively monitor the relative levels of viruses expressing as these different strains of HIV-1 were harvested from on their surface the threshold number of virally embedthe same producer cell line. The strain-specificity of this ded cellular proteins needed to be captured by immunophenomenon is exclusive to HLA-DR proteins as no such magnetic beads. Three different laboratory isolates of marked differences were seen when using magnetic HIV-1 were harvested from acutely infected RAJI-CD4 beads coated with either anti-ICAM-1, -MHC-I, -HLA-DP, cells and immunomagnetic separation of such virus partior -HLA-DQ antibodies. cles was achieved by incubating together magnetic
We have next monitored whether the virus producer cell beads coated with specific monoclonal antibodies with line can also act as a factor influencing the proportion of similar amounts of each virus stock standardized by their viruses harboring the threshold number of host proteins p24 content. Magnetic beads coated with antibodies spenecessary to achieve selection with immunomagnetic cific for ICAM-1, MHC-I, HLA-DP, and HLA-DQ proteins beads. Flow cytometry analysis was first performed on captured HIV-1 LAI , HIV-1 IIIRF , and HIV-1 NL4-3 with an almost studied cell lines prior to virus inoculation. Table 2 shows comparable efficiency (Fig. 1) . However, the amount of that CD4, MHC-I, and ICAM-1 proteins were expressed by viruses recovered with magnetic beads coated with antiall cell lines tested with the exception of ICAM-1 which HLA-DR antibody was 10-to 40-fold higher as compared was not detected on the surface of Molt 4 clone 8 cells. to the level of viruses captured with magnetic beads More importantly, comparison of levels of cell surface HLAcoated with anti-ICAM-1, -MHC-I, -HLA-DP, or HLA-DQ DR, -DP, and -DQ proteins, as reflected by the percentage antibodies. Results from this set of experiments suggest of positive cells and the mean fluorescence intensity (indicthat a greater proportion of viruses have incorporated ative of the number of molecules per single cell shown on the threshold number of host HLA-DR than of other cell a logarithmic scale), showed that expression was high on surface molecules studied, which is needed to permit RAJI-CD4, moderate on HUT 78, low on H9, and absent immunomagnetic isolation.
on Molt 4 clone 8 cells. Immunomagnetic recovery of virus Of particular note are differences in the level of progstocks (HIV-1 NL4-3 ) grown on these human CD4/ lymphoid eny virus captured by immunomagnetic beads coated cell lines was next carried out. Results from Fig. 2 indicate with anti-HLA-DR antibodies. Indeed, three times more that magnetic beads coated with anti-ICAM-1, -MHC-I, HIV-1 NL4-3 were recovered than HIV-1 LAI or HIV-1 IIIRF parti--HLA-DP, and -HLA-DQ antibodies captured low to modercles with the use of anti-HLA-DR-coated magnetic partiate amounts of viruses harvested from either RAJI-CD4 or cles. These data indicate that the amount of cellular HLA-DR proteins inserted on budding viruses can differ from HUT 78 cells. As expected, virus from Molt 4 clone 8 could not be recovered with the use of magnetic beads coated host HLA-DR molecules sufficient to permit immunomagnetic isolation is also influenced by the virus producer cell with anti-ICAM-1, -HLA-DR, -DP, and -DQ antibodies. Progeny virus produced by H9 cells could not be isolated by line. Virus stocks used in our experiments were all stan-magnetic beads coated with anti-HLA-DP and -DQ monoclonal antibodies. Interestingly, anti-HLA-DR antibodies dardized according to their p24 content. It is widely accepted that virus-associated p24 may differ depending, were still the most efficient to capture HIV-1 NL4-3 particles independently of the producer cell line (RAJI-CD4, HUT 78, among other things, on the virally induced cytophatic effect. To evaluate whether this factor could play a role or H9 cells). Furthermore, the amount of virus particles captured with magnetic beads coated with anti-HLA-DR in our observations, we first evaluated the proportion of pelletable virus-associated p24 for each virus stock. Ta-antibodies was six-to sevenfold higher for progeny virus generated by RAJI-CD4 than for viruses harvested from ble 3 shows that the percentage of pelletable p24 was comparable for the three virus stocks harvested from either HUT 78 or H9 cells. These results suggest that the proportion of budding virus particles with the number of RAJI-CD4. However the percentage of virus-associated p24 was consistently lower in progeny virus originating from RAJI-CD4 (28.8 to 46.8%) than from either HUT 78 (73.9%), H9 (64.3%), or Molt 4 clone 8 cells (66.0%). These results suggest that, at least under our experimental con- . 2. Immunomagnetic capture of HIV-1 NL4-3 particles harvested from different human lymphoid cell lines. Immunomagnetic beads were a Percentage of pelletable p24 was determined after ultracentrifugation of each virus stock. incubated with progeny virus (2500 pg of p24) originating from acutely infected RAJI-CD4, HUT 78, H9, and Molt 4 clone 8 cells. The amount b Results shown represent the percentage of virus recovery with anti-HLA-DR-coated beads using the formula: % virus recovery Å 100 1 of recovered viral particles was evaluated with the use of a commercial p24 enzymatic assay. Data shown represent the mean of three determi-(pg of p24 immunomagnetically separated/pg of pelletable virus-associated p24). Determination was achieved using 2500 pg of p24 for each nations { SD (*statistically different from other molecules with a P õ 0.0001; **statistically different from other cell lines with a P õ 0.0001).
virus stock.
ditions, the percentage of virion-associated p24 depends more on the producer cell line than on the virus strain. This is most likely attributed to the higher virus-induced cytopathogenicity in RAJI-CD4 than in others cell lines tested (data not shown). We next determined the percentage of virus recovery when using anti-HLA-DR-coated magnetic beads after taking into account the amount of pelletable virus-associated p24. Virus recovery rate of HIV-1 NL4-3 (100%) was 2-to 4-fold higher than that of HIV-1 LAI (45.8%) and HIV-1 IIIRF (27.4%), respectively, for virus stocks generated in RAJI-CD4 cells. Of interest is the finding that the totality of HIV-1 NL4-3 grown on RAJI-CD4 cells was recovered with immunomagnetic beads coated with anti-HLA-DR antibody. The percentage of immunomagnetically isolated HIV-1 NL4-3 was low and comparable when virus progeny virus were harvested from either coated with anti-HLA-DR antibodies are independent of the percentage of pelletable p24. Furthermore, it confirmed our previous data, suggesting that incorporation based on the use of magnetic beads coated with specific of host HLA-DR molecules into budding viruses is both monoclonal antibodies. Beyond the fact that we constrain-and cell type-specific.
firmed the presence of CD54, MHC-I, and HLA-DR on HLA-DR proteins are also the most abundant cell-HIV-1, results from our study also indicated that incorpoderived membrane components on clinical isolates of ration of host cellular components on newly synthesized HIV-1 grown on primary mitogen-stimulated viruses quantitatively differ depending of the viral strain mononuclear cells and the producer cell line. We have been unable to detect the presence of cellular Similar studies were extended to primary isolates har-HLA-DP and HLA-DQ proteins on HIV-1 NL4-3 grown on H9 vested from PHA-activated normal peripheral blood mocells, which is in agreement with previous studies using nonuclear cells to more closely parallel physiological the same cell line but infected with HIV-1 IIIB (Arthur et al., conditions. The pattern of virally inserted cell membrane 1992; Henderson et al., 1987; Hoxie et al., 1987) . On the proteins in low-passage clinical strains of HIV-1 closely other hand, such host-derived molecules were detected resembles our previous findings with laboratory isolates on HIV-1 NL4-3 harvested from RAJI-CD4 and HUT 78 cells. (Fig. 3) . Indeed, we have observed that HLA-DR proteins
To the best of our knowledge, this is the first demonstraremains the most abundant cell-derived molecules prestion of the presence of cellular HLA-DP and HLA-DQ ent on clinical virus isolates harvested from primary moproteins on budding HIV-1. The inability to isolate prognonuclear cells, although lower levels of host molecules eny virus grown in H9 cells with magnetic beads coated were acquired by primary clinical isolates as compared with anti-HLA-DP and HLA-DQ antibodies is most likely to laboratory strains of HIV-1.
attributed to insufficient amounts of virally embedded cellular HLA-DP and -DQ proteins. Perhaps this amount is DISCUSSION under the minimal threshold number of virally acquired host proteins that is needed to allow an efficient capture Our studies focused on the incorporation within HIVby antibody-coated magnetic beads. Thus, our observa-1 of host HLA-DR proteins based on our preliminary obtions suggest that the level of surface expression would servations, suggesting that this cell surface component then influence the number of virally inserted host HLAis the most abundant virally incorporated host protein.
DP and HLA-DQ proteins within budding virus particles Another factor that urged us to concentrate our efforts since lower levels of cell surface HLA-DP and HLA-DQ on this cellular protein is that it may modulate the biology were detected on H9 cells as compared to HUT 78 cells. of HIV as MHC-II is the physiological counterligand of More importantly, data from our comparative studies CD4 (Doyle and Strominger, 1987) . To evaluate in a semihave indicated that the capacity to acquire cell memquantitative fashion the rate of incorporation of cell membrane proteins on HIV-1, we developed a capture assay brane HLA-DR proteins is virus strain-specific as immu-nomagnetic recovery of HIV-1 NL4-3 is more efficient than ration is not mediated by differences in the percentage of pelletable p24 found in each virus stock. capture of HIV-1 LAI and HIV-1 IIIRF . NL4-3 is a chimeric molecular clone that is separated in two halves by a Constitutive expression of class II molecules is mainly restricted to antigen-presenting cells such as macro-unique EcoRI cleaving site located in vpr gene (Adachi et al., 1986) . Its 5 half is derived from the provirus NY5, phages, B cells, and dendritic cells (Owen and Crumpton, 1987) . In addition, normal peripheral T cells have been while its 3 end originates from the provirus LAI. Since statistically different immunomagnetic (anti-HLA-DR) vi-reported to express MHC-II proteins following antigen or alloantigen stimulation (Evans et al., 1978) . Dendritic rus recovery rates were seen between NL4-3 and LAI grown on the same cell line (RAJI-CD4) and as both virus cells are in close proximity to T cells in the lymph nodes (Austyn et al., 1988; Witmer and Steinman, 1984) and strains share the same 3 half of the genome, it suggests that a genetic determinant located in the 5 half of the these cells are known to express very high levels of MHC-II molecules and to be potent antigen-presenting HIV-1 NL4-3 genome is responsible for the higher incorporation of host HLA-DR proteins. Further studies are cells in vitro and in vivo (Austyn and Morris, 1988; Young and Steinman, 1988) . HIV-1 has been isolated from stimu-needed to identify the viral protein(s) that directly or indirectly lead(s) to higher acquisition of cell-derived HLA-lated CD4/ T lymphocytes (Schnittman et al., 1989) , monocytes/macrophages (Ho et al., 1986; Meltzer et al. , DR molecules on HIV-1. We could not detect any marked differences in the efficency of HLA-DR molecules uptake 1990; Popovic and Gartner, 1987) , and the presence of the virus has also been detected in Langerhan's cells for the three clinical virus isolates tested. We believe that more low-passage clinical strains of HIV-1 will have to (dendritic cells located in the epidermis) (Rappersberger et al., 1988) and in follicular dendritic cells of lymph be analyzed to answer this issue.
Our in vitro studies suggested that the incorporation nodes (Spiegel et al., 1992; Tenner-Racz et al., 1985) . Interestingly, a higher frequency of HIV-1-infected cells of HLA-DR molecules is also influenced by the virus producer cell line. Two different mechanisms, which are not was found in lymphoid tissues, such as lymph nodes, in comparison with the frequency of infected cells in mutually exclusive, may be responsible for the observed phenomenon. The first possibility being that the rate of peripheral blood mononuclear cells (Pantaleo et al., 1991) . Altogether these results suggest that viral parti-HLA-DR incorporation is highly dependent on the levels of HLA-DR expressed on the surface of the producer cell cles, in infected individuals, originate primarily from cells expressing MHC-II molecules. The demonstration that line. The second scenario being that some specific HLA-DR determinants would be more preferentially and/or low-passage clinical isolates of HIV-1 harvested from primary cultures of mononuclear cells do indeed incorpo-efficiently incorporated within budding virions. The demonstration that comparable amounts of viruses were im-rate host HLA-DR proteins further reinforces the in vivo relevance of our studies. munomagnetically captured when HIV-1 NL4-3 was harvested from H9 and HUT 78 cells, two cell lines that
Recently, several studies have provided evidence for the biological functions of virus-acquired host molecules. express different levels of surface HLA-DR, suggests that the surface expression level on the producer cell plays Lee Guo and Hildreth (1995) reported that the cell adhesion molecule CD44 retains its biological activity when a minor role in the rate of incorporation within HIV-1 of cellular constituents. The importance of the genetic incorporated on HIV-1. This is of great interest considering virus bearing this functional molecule on its surface background in the incorporation of host HLA-DR within budding HIV-1 particles is shown by the observation that can adhere to any type of cell that possesses its counterreceptor. As stated by the authors, the incorporation a higher proportion of HIV-1 NL4-3 progeny incorporates cellular HLA-DR proteins when the virus stock is har-of functional adhesion receptors can greatly affect the tropism and infectivity of HIV-1. In another study, a syn-vested from RAJI-CD4 than from either H9 or HUT 78. It is of interest to specify that RAJI-CD4 cells carry different ergy in virus neutralization was shown to occur between an anti-LFA-1 monoclonal antibody and anti-HIV-1 anti-HLA-DR molecules (HLA-DR3 and HLA-DRw10) (Herman et al., 1990 ) than H9 and HUT 78 (HLA-DR4 and HLA-bodies in AIDS plasma (Gomez and Hildreth, 1995) . It was postulated that LFA-1 present on HIV-1 particles DRw53) (Arthur et al., 1995) , which share the same genetic background as H9 is a subclone of HUT 78. These may interact with its counterligand located on target cell surface and make the virus-host cell interaction noticed changes in the immunomagnetic capture of viruses are not mediated by putative changes in the bind-stronger, which in turn would facilitate fusion mediated by virus envelope proteins. Similar experiments were ing affinity of the anti-HLA-DR antibody used (clone 2.06) since it recognizes a monomorphic region of HLA-DR conducted by Arthur et al. (1992) who were able to neutralize virus infection using antisera directed against (Charron and McDevitt, 1979) . Thus, we conclude that a more selective incorporation of some specific HLA-DR HLA-DR. The incorporation of CD55 and CD59 within HIV-1 has been recently reported to be associated with determinants might occur within budding HIV-1 particles. Finally, we were able to demonstrate that the observed protection from complement-mediated destruction of such virions (Saiffudin et al., 1995) . In this study, it was virus strain-and cell type-specificity of HLA-DR incorpo-shown that cellular proteins incorporated on viruses re-In conclusion, our in vitro studies indicate that the acquisition of host HLA-DR molecules by budding HIV-1 main functionally active. Finally, protection against SIV infection in macaques was demonstrated to be conferred is influenced by the virus strain and producer cell. This aspect of the biology of HIV needs to be further investi-by vaccination with MHC-I class I (Chan et al., 1994) or HLA-DR proteins (Arthur et al., 1995) . The authors con-gated as recent observations suggest that virion-bound host proteins retain their normal biological functions. A cluded that the most probable explanation for these protections was due to anti-MHC-I or anti-HLA-DR elicited better understanding on how incorporation of host cell membrane proteins can modulate biological properties antibodies reacting with corresponding molecules on the virus surface. of viruses will provide insights into the possible contribution of nonviral components to the immunopathogenesis The biological significance of the incorporation of host HLA-DR proteins within virus particles has to be deter-of HIV-1. mined. However, the incorporation of cellular HLA-DR molecules within HIV-1 coupled with the previously re-ACKNOWLEDGMENTS ported spontaneous loss of the external envelope gp120
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